PharmiWeb.com - Global Pharma News & Resources

Company Directory - Pharmaco

Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
Woodley BioReg helps pharmaceutical, biopharmaceutical, healthcare, active pharmaceutical ingredient manufacturers and medical device companies develop and manufacture quality products that are effective and safe for patients worldwide.
Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. Xellia is wholly owned by Novo Holdings A/S since 2013 and headquartered in Copenhagen, Denmark.
Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.
Founded in 2009, Zigzag is a privately-owned global leader in Quality Assurance. We are a certified Women Owned company and operate through three local offices placed across the world.
aTyr’s mission is to translate novel biological pathways into innovative therapeutics with improved outcomes for patients. Our focus is on the extracellular functionality and signaling pathways of tRNA synthetases.
Our primary goal is to improve the quality of life of patients with diseases or trauma to the musculoskeletal system. anwerina pursues a patient-centered strategy of equal development and marketing of unique pharmaceuticals and medical technology.
atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Headquartered in Berlin, with offices in New York and London, our vision is to heal mental health disorders so that everyone everywhere can live a more fulfilled life.
bitop is an internationally operating company that focuses on the development and distribution of proprietary over-the-counter (OTC) products based on Ectoin®, as well as on the supply of Ectoin® natural and Glycoin® natural as effective cosmetic active ingredients to global cosmetic manufacturers and brands.
iNova Pharmaceuticals distributes a wide range of market-leading, branded prescription medicines and consumer healthcare products to over 20 countries across Asia, Australasia, and Africa. Our vision is to provide trusted brands that improve people’s health and well-being every day.